J.P. Morgan Private Wealth Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $3.49M | Buy |
+9,734
| New | +$3.49M | 0.01% | 582 |
|
|
2023
Q2 | – | Sell |
-3,297
| Closed | -$1.58M | – | 1524 |
|
|
2023
Q1 | $1.58M | Buy |
3,297
+58
| +2% | +$27.8K | ﹤0.01% | 971 |
|
|
2022
Q4 | $1.36M | Buy |
3,239
+831
| +35% | +$349K | ﹤0.01% | 1004 |
|
|
2022
Q3 | $1M | Buy |
2,408
+188
| +8% | +$78.4K | ﹤0.01% | 1135 |
|
|
2022
Q2 | $1.1M | Sell |
2,220
-23
| -1% | -$11.4K | ﹤0.01% | 1097 |
|
|
2022
Q1 | $1.26M | Sell |
2,243
-323
| -13% | -$182K | ﹤0.01% | 1099 |
|
|
2021
Q4 | $1.94M | Sell |
2,566
-126
| -5% | -$95.2K | ﹤0.01% | 922 |
|
|
2021
Q3 | $2.01M | Buy |
2,692
+501
| +23% | +$374K | ﹤0.01% | 899 |
|
|
2021
Q2 | $1.41M | Buy |
2,191
+460
| +27% | +$296K | ﹤0.01% | 1026 |
|
|
2021
Q1 | $989K | Sell |
1,731
-638
| -27% | -$365K | ﹤0.01% | 1044 |
|
|
2020
Q4 | $1.38M | Sell |
2,369
-144
| -6% | -$83.9K | ﹤0.01% | 877 |
|
|
2020
Q3 | $1.3M | Sell |
2,513
-74
| -3% | -$38.1K | 0.01% | 783 |
|
|
2020
Q2 | $1.17M | Buy |
2,587
+225
| +10% | +$102K | 0.01% | 756 |
|
|
2020
Q1 | $828K | Buy |
2,362
+1,138
| +93% | +$399K | ﹤0.01% | 770 |
|
|
2019
Q4 | $453K | Buy |
1,224
+105
| +9% | +$38.9K | ﹤0.01% | 1087 |
|
|
2019
Q3 | $372K | Buy |
1,119
+141
| +14% | +$46.9K | ﹤0.01% | 1109 |
|
|
2019
Q2 | $306K | Sell |
978
-2
| -0.2% | -$626 | ﹤0.01% | 1141 |
|
|
2019
Q1 | $300K | Buy |
+980
| New | +$300K | ﹤0.01% | 1204 |
|
|
2018
Q4 | – | Sell |
-665
| Closed | -$208K | – | 1458 |
|
|
2018
Q3 | $208K | Buy |
+665
| New | +$208K | ﹤0.01% | 1459 |
|
|
2017
Q3 | – | Sell |
-1,070
| Closed | -$242K | – | 1242 |
|
|
2017
Q2 | $242K | Buy |
+1,070
| New | +$242K | ﹤0.01% | 1087 |
|